Elevated BMI Increases Risk for Complications in Autologous Breast Reconstruction
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 13, 2024 -- For patients undergoing abdominally based autologous free-flap breast reconstruction, the rates of breast and abdominal complications increase with increasing body mass index (BMI), according to a study published in the March issue of Plastic and Reconstructive Surgery.
Laura L. Barnes, M.D., from the University of California, San Francisco, and colleagues conducted a retrospective chart review of all patients who underwent abdominally based autologous free-flap breast reconstruction at their institution between 2004 and 2021. A total of 365 patients (545 breasts) were stratified into five BMI categories: ≤25, 25.01 to 30, 30.01 to 35, 35.01 to 40, and >40 kg/m2. Complication rates were examined across these groups.
The researchers found a significant increase in the rates of several breast complications with increasing BMI at distinct levels, including infection requiring oral antibiotics (BMI >25 kg/m2); any breast complication and any infection (BMI >30 kg/m2); unplanned reoperation, wound breakdown requiring reoperation, infection requiring intravenous antibiotics, and mastectomy flap necrosis (BMI >35 kg/m2); and fat necrosis (BMI >40 kg/m2). In addition, the rates of many abdominal complications increased significantly with increasing BMI at distinct levels, including delayed wound healing (BMI >30 kg/m2) and wound breakdown requiring reoperation (BMI >40kg/m2). The occurrence of any breast complication and any abdominal complication would be minimized with optimal BMI cutoffs of 32.7 and 30.0 kg/m2, respectively.
"Preoperative weight loss may alleviate surgical risk in overweight and obese patients pursuing autologous breast reconstruction," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD
THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.